Related Experiment Video
Updated: Feb 6, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell
Anshuman Panda1,2, Aguirre A de Cubas3, Mark Stein1,4
1Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Abstract:
Although a subset of clear cell renal cell carcinoma (ccRCC) patients respond to immune checkpoint blockade (ICB), predictors of response remain uncertain. We investigated whether abnormal expression of endogenous retroviruses (ERVs) in tumors is associated with local immune checkpoint activation (ICA) and response to ICB. Twenty potentially immunogenic ERVs (πERVs) were identified in ccRCC in The Cancer Genome Atlas data set, and tumors were stratified into 3 groups based on their expression levels. πERV-high ccRCC tumors showed increased immune infiltration, checkpoint pathway upregulation, and higher CD8+ T cell fraction in infiltrating leukocytes compared with πERV-low ccRCC tumors. Similar results were observed in ER+/HER2- breast, colon, and head and neck squamous cell cancers. ERV expression correlated with expression of genes associated with histone methylation and chromatin regulation, and πERV-high ccRCC was enriched in BAP1 mutant tumors. ERV3-2 expression correlated with ICA in 11 solid cancers, including the 4 named above. In a small retrospective cohort of 24 metastatic ccRCC patients treated with single-agent PD-1/PD-L1 blockade, ERV3-2 expression in tumors was significantly higher in responders compared with nonresponders. Thus, abnormal expression of πERVs is associated with ICA in several solid cancers, including ccRCC, and ERV3-2 expression is associated with response to ICB in ccRCC.
Insights
Abnormal expression of endogenous retroviruses (ERVs) in tumors correlates with immune checkpoint activation. Higher ERV3-2 expression predicts better response to immune checkpoint blockade (ICB) in clear cell renal cell carcinoma (ccRCC).
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Predicting response to immune checkpoint blockade (ICB) in clear cell renal cell carcinoma (ccRCC) remains challenging.
- Endogenous retroviruses (ERVs) are increasingly recognized for their role in cancer immunity.
Purpose of the Study:
- To investigate the association between endogenous retrovirus (ERV) expression, immune checkpoint activation (ICA), and ICB response in ccRCC.
- To identify potential biomarkers for ICB treatment efficacy.
Main Methods:
- Identification of 20 potentially immunogenic ERVs (πERVs) in ccRCC using The Cancer Genome Atlas data.
- Stratification of ccRCC tumors into high, medium, and low πERV expression groups.
- Analysis of immune infiltration, checkpoint pathway gene expression, and ERV3-2 levels in relation to ICB response in a cohort of ccRCC patients.
Main Results:
- πERV-high ccRCC tumors exhibited increased immune infiltration and checkpoint pathway upregulation compared to πERV-low tumors.
- ERV expression correlated with histone methylation and chromatin regulation genes, and was enriched in BAP1 mutant ccRCC.
- ERV3-2 expression was associated with ICA across 11 solid cancers and significantly higher in responders versus nonresponders to ICB in ccRCC.
Conclusions:
- Abnormal πERV expression is linked to immune checkpoint activation in ccRCC and other solid tumors.
- ERV3-2 expression serves as a potential predictive biomarker for ICB response in ccRCC patients.
More Related Videos
Related Concept Videos
Retroviruses
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Humoral Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

